What are the Challenges in Nanotechnology-Based Cancer Treatment?
Despite the promising potential, several challenges need to be addressed:
Toxicity: The long-term effects of nanoparticles on human health and the environment are not fully understood. Regulatory Approval: Stringent regulatory requirements must be met to ensure safety and efficacy. Manufacturing: Scalable production of nanoparticles with consistent quality remains a challenge. Targeting Efficiency: Ensuring that nanocarriers selectively target cancer cells without affecting healthy cells is still a work in progress.